5-hydroxy-6-oxo-1,6-dihydropyrazine-2-carboxylic acid, 97%, 250mg

(6R,8aS)-6-(8-amino-1-bromoimidazo[1,5-a]pyrazin-3-yl)hexahydroindolizin-3(2H)-one, 96%, 1g

2,4-Dichloro-6-(methylsulfonyl)pyrimidine, 100mg

Isobutyric Anhydride>95.0%(GC)(T)25mL

Sulforhodamine 101>95.0%(HPLC)(N)200mg

N-Benzyl-N-(methoxymethyl)-N-(trimethylsilylmethyl)-amine (tech), 90%, 100g

N-((2R,3R,4R,5S,6R)-2-Ethoxy-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-3-yl)acetamide, 97%, 1g

tert-Butyl (2R,3R)-3-hydroxy-2-methylazetidine-1-carboxylate, 98%, 500mg

tert-Butyl 2-(1,3-dioxoisoindolin-2-yl)acetate, 95.0%, 10g

Dipropylene glycol monopropyl ether, min 98%, for synthesis, 5L, plastic packaging.

Ethyl 2,3-dicyanopropanoate, 95.0%, 1g

3'-Ethoxy-2,2,2-trifluoroacetophenone, 97.0%, 1g

(4-(Methylsulfonamidomethyl)phenyl)boronic acid, 95.0%, 1g